493 related articles for article (PubMed ID: 15567420)
21. Overexpression of latent transforming growth factor-beta binding protein 1 (LTBP-1) in dioxin receptor-null mouse embryo fibroblasts.
Santiago-Josefat B; Mulero-Navarro S; Dallas SL; Fernandez-Salguero PM
J Cell Sci; 2004 Feb; 117(Pt 6):849-59. PubMed ID: 14762110
[TBL] [Abstract][Full Text] [Related]
22. Latency, activation, and binding proteins of TGF-beta.
Koli K; Saharinen J; Hyytiäinen M; Penttinen C; Keski-Oja J
Microsc Res Tech; 2001 Feb; 52(4):354-62. PubMed ID: 11170294
[TBL] [Abstract][Full Text] [Related]
23. Transcription of the fish Latent TGFbeta-binding protein gene is controlled by estrogen receptor alpha.
Andersson ML; Eggen RI
Toxicol In Vitro; 2006 Jun; 20(4):417-25. PubMed ID: 16171970
[TBL] [Abstract][Full Text] [Related]
24. Growth factor-binding sequence in human alpha2-macroglobulin targets the receptor-binding site in transforming growth factor-beta.
Arandjelovic S; Freed TA; Gonias SL
Biochemistry; 2003 May; 42(20):6121-7. PubMed ID: 12755614
[TBL] [Abstract][Full Text] [Related]
25. Role of latent TGF-beta 1 binding protein in vascular remodeling.
Kanzaki T; Shiina R; Saito Y; Oohashi H; Morisaki N
Biochem Biophys Res Commun; 1998 May; 246(1):26-30. PubMed ID: 9600062
[TBL] [Abstract][Full Text] [Related]
26. Fibronectin and heparin binding domains of latent TGF-beta binding protein (LTBP)-4 mediate matrix targeting and cell adhesion.
Kantola AK; Keski-Oja J; Koli K
Exp Cell Res; 2008 Aug; 314(13):2488-500. PubMed ID: 18585707
[TBL] [Abstract][Full Text] [Related]
27. Lack of the latent transforming growth factor beta binding protein in malignant, but not benign prostatic tissue.
Eklöv S; Funa K; Nordgren H; Olofsson A; Kanzaki T; Miyazono K; Nilsson S
Cancer Res; 1993 Jul; 53(13):3193-7. PubMed ID: 7686449
[TBL] [Abstract][Full Text] [Related]
28. Isoform-specific activation of latent transforming growth factor beta (LTGF-beta) by reactive oxygen species.
Jobling MF; Mott JD; Finnegan MT; Jurukovski V; Erickson AC; Walian PJ; Taylor SE; Ledbetter S; Lawrence CM; Rifkin DB; Barcellos-Hoff MH
Radiat Res; 2006 Dec; 166(6):839-48. PubMed ID: 17149983
[TBL] [Abstract][Full Text] [Related]
29. Characterization of latent TGF-beta activation by murine peritoneal macrophages.
Nunes I; Shapiro RL; Rifkin DB
J Immunol; 1995 Aug; 155(3):1450-9. PubMed ID: 7636210
[TBL] [Abstract][Full Text] [Related]
30. Immunoelectron microscopic localization of transforming growth factor beta 1 and latent transforming growth factor beta 1 binding protein in human gastrointestinal carcinomas: qualitative difference between cancer cells and stromal cells.
Mizoi T; Ohtani H; Miyazono K; Miyazawa M; Matsuno S; Nagura H
Cancer Res; 1993 Jan; 53(1):183-90. PubMed ID: 8416744
[TBL] [Abstract][Full Text] [Related]
31. (Latent) transforming growth factor beta in liver parenchymal cells, its injury-dependent release, and paracrine effects on rat hepatic stellate cells.
Roth S; Michel K; Gressner AM
Hepatology; 1998 Apr; 27(4):1003-12. PubMed ID: 9537440
[TBL] [Abstract][Full Text] [Related]
32. Expression and matrix deposition of latent transforming growth factor beta binding proteins in normal and fibrotic rat liver and transdifferentiating hepatic stellate cells in culture.
Breitkopf K; Lahme B; Tag CG; Gressner AM
Hepatology; 2001 Feb; 33(2):387-96. PubMed ID: 11172340
[TBL] [Abstract][Full Text] [Related]
33. P311 binds to the latency associated protein and downregulates the expression of TGF-beta1 and TGF-beta2.
Paliwal S; Shi J; Dhru U; Zhou Y; Schuger L
Biochem Biophys Res Commun; 2004 Mar; 315(4):1104-9. PubMed ID: 14985127
[TBL] [Abstract][Full Text] [Related]
34. Role of carbohydrate structures in the binding of beta1-latency-associated peptide to ligands.
Yang Y; Dignam JD; Gentry LE
Biochemistry; 1997 Sep; 36(39):11923-32. PubMed ID: 9305986
[TBL] [Abstract][Full Text] [Related]
35. Expression of truncated latent TGF-beta-binding protein modulates TGF-beta signaling.
Mazzieri R; Jurukovski V; Obata H; Sung J; Platt A; Annes E; Karaman-Jurukovska N; Gleizes PE; Rifkin DB
J Cell Sci; 2005 May; 118(Pt 10):2177-87. PubMed ID: 15870109
[TBL] [Abstract][Full Text] [Related]
36. Modulation of the functional binding sites for TGF-beta on the type II receptor leads to suppression of TGF-beta signaling.
Shimanuki T; Hara T; Furuya T; Imamura T; Miyazono K
Oncogene; 2007 May; 26(23):3311-20. PubMed ID: 17146441
[TBL] [Abstract][Full Text] [Related]
37. Disruption of LTBP-4 function reduces TGF-beta activation and enhances BMP-4 signaling in the lung.
Koli K; Wempe F; Sterner-Kock A; Kantola A; Komor M; Hofmann WK; von Melchner H; Keski-Oja J
J Cell Biol; 2004 Oct; 167(1):123-33. PubMed ID: 15466481
[TBL] [Abstract][Full Text] [Related]
38. LTBP-1 blockade in dioxin receptor-null mouse embryo fibroblasts decreases TGF-beta activity: Role of extracellular proteases plasmin and elastase.
Gomez-Duran A; Mulero-Navarro S; Chang X; Fernandez-Salguero PM
J Cell Biochem; 2006 Feb; 97(2):380-92. PubMed ID: 16187295
[TBL] [Abstract][Full Text] [Related]
39. Identification and characterization of a new latent transforming growth factor-beta-binding protein, LTBP-4.
Saharinen J; Taipale J; Monni O; Keski-Oja J
J Biol Chem; 1998 Jul; 273(29):18459-69. PubMed ID: 9660815
[TBL] [Abstract][Full Text] [Related]
40. Transforming growth factor beta 1 and its latent form binding protein-1 associate with elastic fibres in human dermis: accumulation in actinic damage and absence in anetoderma.
Karonen T; Jeskanen L; Keski-Oja J
Br J Dermatol; 1997 Jul; 137(1):51-8. PubMed ID: 9274625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
